• 1
    Dutton RW, Bradley LM, Swain SL. T cell memory. Annu Rev Immunol 1998; 16 : 20123.
  • 2
    Sallusto F, Mackay CR, Lanzavecchia A. The role of chemokine receptors in primary, effector and memory immune responses. Annu Rev Immunol 2000; 593 : 62045.
  • 3
    Akbar AN, Salmon M, Savill J, Janossy G. A possible role for bcl-2 in regulating T cell memory-a ‘balancing act’ between cell death and survival. Immunol Today 1993; 14 : 52631.
  • 4
    Ahmed R, Gray D. Immunological memory and protective immunity. Understanding their relation. Science 1996; 272 : 5460.
  • 5
    Salmon M, Pilling D, Borthwick NJ, Viner N, Janossy G, Bacon PA, Akbar AN. The progressive differentiation of primed T cells is associated with an increasing susceptibility to apoptosis. Eur J Immunol 1994; 24 : 8929.
  • 6
    Itoh M, Takahashi T, Sakaguchi N, Kuniyasu Y, Shimizu J, Otsuka F, Sakaguchi S. Thymus and autoimmunity: production of CD25+ CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance. J Immunol 1999; 162 : 531726.
  • 7
    Jonuleit H, Schmitt E, Stassen M, Tuettenberg A, Knop J, Enk AH. Identification and functional characterization of human CD4+ CD25+ T cells with regulatory properties isolated from peripheral blood. J Exp Med 2001; 193 : 128594.
  • 8
    Levings MK, Sangregorio R, Roncarolo MG. Human CD25+ CD4+ T regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. J Exp Med 2001; 193 : 1295302.
  • 9
    Read S, Malmstrom V, Powrie F. Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25+ CD4+ regulatory cells that control intestinal inflammation. J Exp Med 2000; 192 : 295302.
  • 10
    Taams L, Smith J, Rustin MH, Salmon M, Poulter LW, Akbar AN. Human anergic/suppressive CD4+ CD25+ T cells: a highly differentiated and apoptosis-prone population. Eur J Immunol 2001; 31 : 112231.
  • 11
    Dieckmann D, Plottner H, Berchtold S, Berger T, Schuler G. Ex vivo isolation and characterization of CD4+ CD25+ T cells with regulatory properties from human blood. J Exp Med 2001; 193 : 130310.
  • 12
    Effros RB, Pawelec G. Replicative senescence of T cells: does the Hayflick Limit lead to immune exhaustion? Immunol Today 1997; 18 : 4504.
  • 13
    Pan C, Xue BH, Ellis TM, Peace DJ, Diaz MO. Changes in telomerase activity and telomere length during human T lymphocyte senescence. Exp Cell Res 1997; 231 : 34653.
  • 14
    Allsopp RC, Chang E, Kashefi-Aazam M, Rogaev EI, Piatyszek MA, Shay J, Harley CB. Telomere shortening is associated with cell division in vitro and in vivo. Exp Cell Res 1995; 220 : 194200.
  • 15
    Rufer N, Brummendorf TH, Kolvraa S, Bischoff C, Christensen K, Wadsworth L, Schulzer M, Lansdorp PM. Telomere fluorescence measurements in granulocytes and T lymphocyte subsets point to a high turnover of hematopoietic stem cells and memory T cells in early childhood. J Exp Med 1999; 190 : 15767.
  • 16
    Vaziri H, Dragowska W, Allsopp RC, Thomas TE, Harley CB, Lansdorp PM. Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age. Proc Natl Acad Sci USA 1994; 91 : 985760.
  • 17
    Bodnar AG, Kim NW, Effros RB, Chiu CP. Mechanism of telomerase induction during T cell activation. Exp Cell Res 1996; 228 : 5864.
  • 18
    Levy MZ, Allsopp RC, Futcher AB, Greider CW, Harley CB. Telomere end-replication problem and cell aging. J Mol Biol 1992; 225 : 95160.
  • 19
    Rufer N, Dragowska W, Thornbury G, Roosnek E, Lansdorp PM. Telomere length dynamics in human lymphocyte subpopulations measured by flow cytometry. Nat Biotechnol 1998; 16 : 7437.
  • 20
    Weng NP, Levine BL, June CH, Hodes RJ. Human naive and memory T lymphocytes differ in telomeric length and replicative potential. Proc Natl Acad Sci USA 1995; 92 : 110914.
  • 21
    Weng NP, Hodes RJ. The role of telomerase expression and telomere length maintenance in human and mouse. J Clin Immunol 2000; 20 : 25767.
  • 22
    Weng NP, Hathcock KS, Hodes RJ. Regulation of telomere length and telomerase in T and B cells: a mechanism for maintaining replicative potential. Immunity 1998; 9 : 1517.
  • 23
    Weng NP, Palmer LD, Levine BL, Lane HC, June CH, Hodes RJ. Tales of tails: regulation of telomere length and telomerase activity during lymphocyte development, differentiation, activation, and aging. Immunol Rev 1997; 160 : 4354.
  • 24
    Taams LS, Vukmanovic-Stejic M, Smith J et al. Antigen-specific T cell suppression by human CD4+CD25+ regulatory T cells. Eur J Immunol 2002; 32 : 162130.
  • 25
    Akbar AN, Borthwick N, Salmon M et al. The significance of low bcl-2 expression by CD45RO T cells in normal individuals and patients with acute viral infections. The role of apoptosis in T cell memory. J Exp Med 1993; 178 : 42738.
  • 26
    Akbar AN, Borthwick NJ, Wickremasinghe RG, et al. Interleukin-2 receptor common γ-chain signalling cytokines regulate activated T cell apoptosis in response to growth factor withdrawal: selective induction of anti-apoptotic (bcl-2, bcl-xL), but not pro-apoptotic (bax, bcl-xs) gene expression. Eur J Immunol 1996; 26 : 2949.
  • 27
    Vella AT, Dow S, Potter TA, Kappler J, Marrack P. Cytokine-induced survival of activated T cells in vitro and in vivo. Proc Natl Acad Sci USA 1998; 95 : 381015.
  • 28
    Lenardo M, Chan KM, Hornung F, McFarland H, Siegel R, Wang J, Zheng L. Mature T lymphocyte apoptosis – immune regulation in a dynamic and unpredictable antigenic environment. Annu Rev Immunol 1999; 17 : 22153.
  • 29
    Pilling D, Akbar AN, Girdlestone J et al. Interferon β mediates stromal cell rescue of T cells from apoptosis. Eur J Immunol 1999; 29 : 104150.
  • 30
    Marrack P, Kappler J, Mitchell T. Type I interferons keep activated T cells alive. J Expl Med 1999; 189 : 5219.
  • 31
    Scheel-Toellner D, Pilling D, Akbar AN, Hardie D, Lombardi G, Salmon M, Lord JM. Inhibition of T cell apoptosis by IFN-beta rapidly reverses nuclear translocation of protein kinase C-delta. Eur J Immunol 1999; 29 : 260312.
  • 32
    Maloy KJ, Powrie F. Regulatory T cells in the control of immune pathology. Nat Immunol 2001; 2 : 81622.
  • 33
    Sakaguchi S. Regulatory T cells: key controllers of immunologic self-tolerance. Cell 2000; 101 : 4558.
  • 34
    Shevach EM. CD4+ CD25+ suppressor T cells: more questions than answers. Nat Rev Immunol 2002; 2 : 389400.
  • 35
    Stephens LA, Mottet C, Mason D, Powrie F. Human CD4+ CD25+ thymocytes and peripheral T cells have immune suppressive activity in vitro. Eur J Immunol 2001; 31 : 124754.
  • 36
    Stephens LA, Mason D. CD25 is a marker for CD4+ thymocytes that prevent autoimmune diabetes in rats, but peripheral T cells with this function are found in both CD25+ and CD25 subpopulations. J Immunol 2000; 165 : 310510.
  • 37
    Papiernik M, De Moraes ML, Pontoux C, Vasseur F, Penit C. Regulatory CD4 T cells. expression of IL-2R alpha chain, resistance to clonal deletion and IL-2 dependency. Int Immunol 1998; 10 : 3718.
  • 38
    Saoudi A, Seddon B, Fowell D, Mason D. The thymus contains a high frequency of cells that prevent autoimmune diabetes on transfer into prediabetic recipients. J Exp Med 1996; 184 : 23938.
  • 39
    Sakaguchi S, Takahashi T, Nishizuka Y. Study on cellular events in postthymectomy autoimmune oophoritis in mice. I. Requirement of Lyt-1 effector cells for oocytes damage after adoptive transfer. J Exp Med 1982; 156 : 156576.
  • 40
    Sakaguchi S, Takahashi T, Nishizuka Y. Study on cellular events in postthymectomy autoimmune oophoritis in mice. I. Requirement of Lyt-1 effector cells for oocytes damage after adoptive transfer. J Exp Med 1982; 156 : 157786.
  • 41
    Singh B, Read S, Asseman C, Malmstrom V et al. Control of intestinal inflammation by regulatory T cells. Immunol Rev 2001; 182 : 190200.
  • 42
    Asano M, Toda M, Sakaguchi N, Sakaguchi S. Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J Exp Med 1996; 184 : 38796.
  • 43
    Thorstenson KM, Khoruts A. Generation of anergic and potentially immunoregulatory CD25+ CD4 T cells in vivo after induction of peripheral tolerance with intravenous or oral antigen. J Immunol 2001; 167 : 18895.
  • 44
    Zhang X, Izikson L, Liu L, Weiner HL. Activation of CD25+ CD4+ regulatory T cells by oral antigen administration. J Immunol 2001; 167 : 424553.
  • 45
    Taguchi O, Kontani K, Ikeda H, Kezuka T, Takeuchi M, Takahashi T, Takahashi T. Tissue-specific suppressor T cells involved in self-tolerance are activated extrathymically by self-antigens. Immunology 1994; 82 : 3659.
  • 46
    Chen ZK, Cobbold SP, Waldmann H, Metcalfe S. Amplification of natural regulatory immune mechanisms for transplantation tolerance. Transplantation 1996; 62 : 12006.
  • 47
    Waldmann H, Cobbold S. Regulating the immune response to transplants. A role for CD4+ regulatory cells? Immunity 2001; 14 : 399406.
  • 48
    Hall BM, Fava L, Chen J, Plain KM, Boyd RA, Spicer ST, Berger MF. Anti-CD4 monoclonal antibody-induced tolerance to MHC-incompatible cardiac allografts maintained by CD4+ suppressor T cells that are not dependent upon IL-4. J Immunol 1998; 161 : 514756.
  • 49
    Jonuleit H, Schmitt E, Schuler G, Knop J, Enk AH. Induction of interleukin 10-producing, nonproliferating CD4+ T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J Exp Med 2000; 192 : 121322.
  • 50
    Gregori S, Casorati M, Amuchastegui S, Smiroldo S, Davalli AM, Adorini L. Regulatory T cells induced by 1 alpha,25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance. J Immunol 2001; 167 : 194553.
  • 51
    Barrat FJ, Cua DJ, Boonstra A et al. In vitro generation of interleukin 10-producing regulatory CD4+ T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J Exp Med 2002; 195 : 60316.
  • 52
    Lombardi G, Sidhu S, Batchelor R, Lechler R. Anergic T cells as suppressor cells in vitro. Science 1994; 264 : 15879.
  • 53
    Lombardi G, Hargreaves R, Sidhu S et al. Antigen presentation by T cells inhibits IL-2 production and induces IL-4 release due to altered cognate signals. J Immunol 1996; 156 : 276975.
  • 54
    Lamb JR, Skidmore BJ, Green N, Chiller JM, Feldmann M. Induction of tolerance in influenza virus-immune T lymphocyte clones with synthetic peptides of influenza hemagglutinin. J Exp Med 1983; 157 : 143447.
  • 55
    Ko HS, Fu SM, Winchester RJ, Yu DT, Kunkel HG. Ia determinants on stimulated human T lymphocytes. Occurrence on mitogen- and antigen-activated T cells. J Exp Med 1979; 150 : 24655.
  • 56
    LaSalle JM, Tolentino PJ, Freeman GJ, Nadler LM, Hafler DA. Early signaling defects in human T, cells anergized by T, cell presentation of autoantigen. J Exp Med 1992; 176 : 17786.
  • 57
    Taams LS, Van Eden W, Wauben MH. Antigen presentation by T cells versus professional antigen-presenting cells (APC): differential consequences for T cell activation and subsequent T cell–APC interactions. Eur J Immunol 1999; 29 : 154350.
  • 58
    Broeren CP, Wauben MH, Lucassen MA, Van Meurs M, Van Kooten PJ, Boog CJ, Claassen E, Van Eden W. Activated rat T cells synthesize and express functional major histocompatibility class II antigens. Immunology 1995; 84 : 193201.
  • 59
    Lombardi G, Dunne PJ, Scheel-Toellner D et al. Type 1 IFN maintains the survival of anergic CD4+ T cells. J Immunol 2000; 165 : 37829.
  • 60
    Ng WF, Duggan PJ, Ponchel F, Matarese G, Lombardi G, Edwards AD, Isaacs JD, Lechler RI. Human CD4+ CD25+ cells: a naturally occurring population of regulatory T cells. Blood 2001; 98 : 273644.
  • 61
    Wing K, Ekmark A, Karlsson H, Rudin A, Suri-Payer E. Characterization of human CD25+ CD4+ T cells in thymus, cord and adult blood. Immunology 2002; 106 : 1909.
  • 62
    Almeida AR, Legrand N, Papiernik M, Freitas AA. Homeostasis of peripheral CD4+ T cells: IL-2R alpha and IL-2 shape a population of regulatory cells that controls CD4+ T cell numbers. J Immunol 2002; 169 : 485060.
  • 63
    Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4+ CD25+ regulatory T cells. Nat. Immunol 2003; 4 : 3306.
  • 64
    Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003; 299 : 105761.
  • 65
    Bach JF. Regulatory T cells under scrutiny. Nat Rev Immunol 2003; 3 : 18998.
  • 66
    Hayday A, Tigelaar R. Immunoregulation in the tissues by γδ T cells. Nat Rev Immunol 2003; 3 : 23342.
  • 67
    Hargreaves RG, Borthwick NJ, Montani MG, Piccolella E, Carmichael P, Lechler RI, Akbar AN, Lombardi G. Dissociation of T cell anergy from apoptosis by blockade of Fas/Apo-1 (CD95) signaling. J Immunol 1997; 158 : 3099107.
  • 68
    Schwartz RH. T cell anergy. Annu Rev Immunol 2003; 21 : 30554.
  • 69
    Taams LS, Van Eden W, Wauben MH. Dose-dependent induction of distinct anergic phenotypes: multiple levels of T cell anergy. J Immunol 1999; 162 : 197481.
  • 70
    Chai JG, Bartok I, Chandler P, Vendetti S, Antoniou A, Dyson J, Lechler R. Anergic T cells act as suppressor cells in vitro and in vivo. Eur J Immunol 1999; 29 : 68692.
  • 71
    Hayashi RJ, Loh DY, Kanagawa O, Wang F. Differences between responses of naive and activated T cells to anergy induction. J Immunol 1998; 160 : 338.
  • 72
    Marelli-Berg FM, Weetman A, Frasca L, Deacock SJ, Imami N, Lombardi G, Lechler RI. Antigen presentation by epithelial cells induces anergic immunoregulatory CD45RO+ T cells and deletion of CD45RA+ T cells. J Immunol 1997; 159 : 585361.
  • 73
    Takahashi T, Kuniyasu Y, Toda M, Sakaguchi N, Itoh M, Iwata M, Shimizu J, Sakaguchi S. Immunologic self-tolerance maintained by CD25+ CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int Immunol 1998; 10 : 196980.